칸나비디올(CBD) 시장 : 원료별, 제품별, 용도별, 투여 경로별, 유통 채널별, 세계 예측(2024-2032년)

Global Cannabidiol (CBD) Market will witness 17.9% CAGR between 2024 and 2032, driven by rising research and development into its potential benefits. As scientific studies continue to explore CBD's therapeutic properties, including its potential for alleviating pain, anxiety, and sleep disorders, consumer interest is expanding.

Research advancements are uncovering new applications for CBD in various health and wellness products, ranging from supplements to skincare. This growing body of evidence supports CBD's efficacy and safety, further fueling its market appeal. For instance, in February 2024, new research from CU Boulder indicated that cannabis products high in the non-intoxicating compound CBD may alleviate anxiety more effectively than THC-dominant products and without the associated side effects.

Additionally, regulatory changes and increased acceptance of hemp-derived products contribute to the rising demand. The continuous investment in R&D by companies seeking to develop innovative CBD-based solutions is pivotal in shaping the market, as it enhances understanding, broadens applications, and builds consumer trust in CBD's benefits. This trend underscores the dynamic nature of the CBD market and its evolving role in the wellness industry.

The overall Cannabidiol (CBD) Industry is classified based on the source, product, application, route of administration, distribution channel, and region.

Based on source, the cannabidiol (CBD) market revenue from the marijuana segment will register a commendable CAGR from 2024 to 2032. As interest in cannabis-derived products rises, CBD has become a popular choice for those seeking relief from pain, anxiety, and other health issues without the psychoactive effects of THC. Consumers and researchers alike are increasingly drawn to CBD's potential health benefits and its applications in wellness and medical products. This trend underscores the evolving role of CBD in the broader cannabis market and its appeal as a therapeutic option.

In terms of product, the oral segment will witness an appreciable growth from 2024 to 2032. Oral CBD products, such as capsules, tinctures, and gummies, offer a convenient and discrete method for users to incorporate CBD into their daily routines. This delivery method ensures consistent dosing and is favored for its ease of use and effectiveness in managing conditions like anxiety, pain, and sleep disorders. The growth in consumer preference for oral CBD products is driven by their perceived benefits, reliability, and the expanding availability of high-quality, clinically tested formulations. As awareness and acceptance of CBD increase, oral CBD products continue to gain popularity, boosting market demand.

Europe cannabidiol (CBD) market will exhibit a notable CAGR from 2024 to 2032. European consumers are increasingly turning to CBD for its potential health benefits, including relief from anxiety, pain, and sleep disorders. The expanding legalization of hemp-derived CBD products across various European countries is driving market expansion, with increased availability in retail and online channels. Additionally, growing awareness and scientific research into CBD's therapeutic effects contribute to its popularity. As European regulations evolve to accommodate and standardize CBD products, the market is expected to continue its upward trajectory, reflecting broader acceptance and demand.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing medical applications of CBD
    • 3.2.1.2 Increasing product adoption and utilization owing to government approvals
    • 3.2.1.3 Changing regulatory landscape for approval of CBD products across region
    • 3.2.1.4 Increasing sales of CBD products in retail stores
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with CBD oil
    • 3.2.2.2 Counterfeit and synthetic products available in the market
    • 3.2.2.3 High cost of CBD products
    • 3.2.2.4 Complex prescription process
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Marijuana
• 5.3 Hemp

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oil
  • 6.2.1 Full-spectrum CBD oil
  • 6.2.2 Broad-spectrum CBD oil
• 6.3 Topicals
  • 6.3.1 Transdermal patches
  • 6.3.2 Creams and roll-on
• 6.4 Oral
  • 6.4.1 Tablet
  • 6.4.2 Capsules
  • 6.4.3 Tinctures
• 6.5 CBD inhalers
• 6.6 Suppository
• 6.7 Isolates
• 6.8 Vape oil
• 6.9 Other products

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Anxiety/ stress
• 7.3 Sleep/insomnia
• 7.4 Chronic pain
• 7.5 Migraines
• 7.6 Skin care
• 7.7 Seizures
• 7.8 Joint pain & inflammation
• 7.9 Other applications

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Oral
• 8.3 Topical
• 8.4 Inhalation
• 8.5 Transdermal patches
• 8.6 Rectal
• 8.7 Sublingual

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Online
• 9.3 Offline
  • 9.3.1 Hospital pharmacy
  • 9.3.2 Retail stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 Aurora Cannabis
• 11.2 Charlotte's Web
• 11.3 Canopy Growth Corporation
• 11.4 CV Sciences, Inc.
• 11.5 Endoca
• 11.6 Elixinol
• 11.7 Folium Biosciencesilray
• 11.8 Gaia Herbs, LLC,
• 11.9 GW Pharmaceuticals
• 11.10 Isodiol International Inc
• 11.11 KOI CBD
• 11.12 Medical Marijuana, Inc.
• 11.13 Medterra
• 11.14 NuLeaf Naturals, LLC,
• 11.15 Tterrapharma
• 11.16 Tilray
• 11.17 Vapen CBD